Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-13 of 13
Keywords: Hypercholesterolemia
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Subject Area:
Cardiovascular System
Tea Skaaby, Lise Lotte Nystrup Husemoen, Charlotta Pisinger, Torben Jørgensen, Betina Heinsbæk Thuesen, Mogens Fenger, Allan Linneberg
Journal:
Cardiology
Cardiology (2012) 123 (1): 62–70.
Published Online: 12 September 2012
... the association between vitamin D levels and 5-year changes in blood pressure, lipid profile and incidence of the metabolic syndrome, hypertension and hypercholesterolemia. Methods: A random sample of 6,784 individuals aged 30–60 years from a general population was investigated in the Inter99 study in 1999–2001...
Journal Articles
Subject Area:
Cardiovascular System
David Busseuil, Yanfen Shi, Mélanie Mecteau, Geneviève Brand, Marc-Antoine Gillis, Eric Thorin, Caroline Asselin, Philippe Roméo, Tack Ki Leung, Jean-Gilles Latour, Christine Des Rosiers, Muriel Bouly, Eric Rhéaume, Jean-Claude Tardif
Journal:
Cardiology
Cardiology (2011) 117 (3): 234–242.
Published Online: 08 January 2011
... or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Heart rate Diastolic dysfunction Collagen Echocardiography Hypercholesterolemia...
Journal Articles
Subject Area:
Cardiovascular System
Journal:
Cardiology
Cardiology (1994) 85 (3-4): 244–254.
Published Online: 18 November 2008
...E. Steinhagen-Thiessen Simvastatin and pravastatin, two 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, were compared in a multinational, randomized, double-blind trial. Patients demonstrating moderate hypercholesterolemia after 10 weeks on a lipid-lowering diet received 6 weeks...
Journal Articles
Subject Area:
Cardiovascular System
P. Brudi, J.P. Reckless, D.P. Henry, T. Pomykaj, S.T. Lim, R. Massaad, K. Vandormael, A.O. Johnson-Levonas
Journal:
Cardiology
Cardiology (2009) 113 (2): 89–97.
Published Online: 15 November 2008
... profiles and use of concomitant medications presented for each statin potency stratum 27 06 2008 13 08 2008 15 11 2008 Statin Ezetimibe/simvastatin Hypercholesterolemia Efficacy Coronary heart disease Lowering low-density lipoprotein cholesterol (LDL-C) reduces...
Journal Articles
Subject Area:
Cardiovascular System
Journal:
Cardiology
Cardiology (1990) 77 (Suppl. 4): 58–65.
Published Online: 12 November 2008
...David W. Bilheimer 3-Hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibitors are gaining widespread use in the treatment of hypercholesterolemia. Clinical experience with lovastatin, which is approaching 4 years in many patients, indicates that it is well tolerated. Short-term adverse...
Journal Articles
Subject Area:
Cardiovascular System
Journal:
Cardiology
Cardiology (1990) 77 (Suppl. 4): 33–38.
Published Online: 12 November 2008
...Willem Erkelens Single-drug therapy is often not sufficient to lower total and low-density lipoprotein (LDL) cholesterol levels in patients with familial hypercholesterolemia to desirable or target levels. Therefore, combination drug therapy is often necessary.The most potent therapy to achieve...
Journal Articles
Subject Area:
Cardiovascular System
Journal:
Cardiology
Cardiology (1990) 77 (Suppl. 4): 2–7.
Published Online: 12 November 2008
...Dag S. Thelle Some people may argue that one cannot, in a strict sense of the word, speak about the ‘epidemiology of hypercholesterolemia’ Epidemiology is a systematic description of the distribution of diseases and causally related factors, and hypercholesterolemia (disregarding the choice of cut...
Journal Articles
Subject Area:
Cardiovascular System
Journal:
Cardiology
Cardiology (1998) 90 (3): 153–159.
Published Online: 15 October 2008
... of endothelial function in patients with cardiovascular risk factors (hypercholesterolemia, smoking, hypertension, diabetes and advanced age) or with several chronic cardiovascular disorders (coronary, peripheral and cerebral vascular disease, and mild-to-moderate heart failure). LA administration is likely...
Journal Articles
Subject Area:
Cardiovascular System
Ole Faergeman, Laurie Hill, Eberhard Windler, Olov Wiklund, Roland Asmar, Emma Duffield, Froukje Sosef
Journal:
Cardiology
Cardiology (2008) 111 (4): 219–228.
Published Online: 23 April 2008
... to optimal effect. The ECLIPSE study was designed to compare the efficacy and safety of force-titrated treatment with rosuvastatin (10–40 mg) with that of atorvastatin (10–80 mg) in high-risk patients with hypercholesterolemia. Methods: In this 24-week, open-label, randomized, multinational, parallel-group...
Journal Articles
Subject Area:
Cardiovascular System
Journal:
Cardiology
Cardiology (2008) 111 (2): 140–146.
Published Online: 31 March 2008
... plasma levels of soluble adhesion molecules in patients with hypercholesterolemia before and after 3 months of treatment with atorvastatin and evaluated possible relations to the mutations in low-density lipoprotein receptor (LDLR) gene. In patients with no LDLR gene polymorphism (group A), lower...
Journal Articles
Subject Area:
Cardiovascular System
Journal:
Cardiology
Cardiology (2006) 105 (4): 213–218.
Published Online: 11 May 2006
... years; males 51.6%) while 222 did not (control). CAD (OR 3.150, 95% CI 2.05–4.83; p < 0.001, r = 0.3), hypertension (OR 2.918, 95% CI 1.85–4.60; p < 0.001, r = 0.2), diabetes mellitus (OR 2.542, 95% CI 1.62–3.97; p < 0.001, r = 0.1), and hypercholesterolemia (OR 1.823, 95% CI 1.22–2.74; p...
Journal Articles
Subject Area:
Cardiovascular System
Journal:
Cardiology
Cardiology (2004) 102 (1): 52–60.
Published Online: 28 April 2004
...-Rad Labs, Irvine, Calif., USA). Any unscheduled repeat measurements performed by these laboratories and measurements from local laboratories at the time of an adverse event were also included in the safety database. Men or women who had primary hypercholesterolemia (familial or nonfamilial...
Journal Articles
Subject Area:
Cardiovascular System
Journal:
Cardiology
Cardiology (2003) 99 (3): 126–139.
Published Online: 27 June 2003
... inhibition. It is approved for use at doses of 10–40 mg once daily to reduce low-density lipoprotein (LDL) cholesterol, increase high-density lipoprotein (HDL) cholesterol and improve other lipid measures in dyslipidemic patients. In a dose-ranging study in mild/moderate hypercholesterolemia, rosuvastatin...